Maravai LifeSciences Holdings, Inc. reaffirmed financial guidance for the full year 2024. Revenue expectations for 2024 remain in the range of $265.0 million to $285.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.61 USD | +1.77% | -0.69% | +31.45% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.45% | 1.14B | |
-41.97% | 7.92B | |
+5.99% | 3.51B | |
-4.31% | 2.18B | |
-21.69% | 1.97B | |
-24.94% | 1.58B | |
+26.75% | 792M | |
-9.83% | 690M | |
-26.33% | 532M | |
+3.38% | 303M |
- Stock Market
- Equities
- MRVI Stock
- News Maravai LifeSciences Holdings, Inc.
- Maravai LifeSciences Holdings, Inc. Reaffirms Financial Guidance for the Full Year 2024